11 March 2022
MYCELX Technologies Corporation
Dealings by Directors
MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company, announces, further to the Placing and Subscription this morning, the following participation by Directors of the Company.
| Director | Shares held prior to Admission | New Shares Purchased | Shares held post Admission | Percentage of Enlarged Issued Share Capital |
| Thomas Lamb | 25,000 | 267,175 | 292,175 | 1.28% |
| Connie Mixon | 2,514,469 | 38,167 | 2,552,636 | 11.18% |
| Andre Schnabl | 8,246 | 38,167 | 46,413 | 0.20% |
Total Voting Rights
In conformity with the FCA's Disclosure Guidance and Transparency Rules (the "Rules") provision 5.6.1, the Company would like to notify the market that following Admission on 21 March 2022 its issued share capital will consist of 22,828,023 Common Shares of US$0.025 each.
Shareholders should use 22,828,023 as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.
Terms and definitions used in this announcement shall have the same meaning as ascribed to them in the Placing and Subscription Announcement released at 7:00 a.m. on 11 March 2022, unless the context requires otherwise.
For further information please contact:
| MYCELX Technologies Corporation Connie Mixon, CEO Kim Slayton, CFO
|
Tel: +1 888 306 6843 |
| Canaccord Genuity, Nominated Adviser Henry Fitzgerald-O'Connor Gordon Hamilton
|
Tel: + 44 20 7523 8000 |
| | |
Notifications of transactions of persons discharging managerial responsibility or connected persons
| 1
| Details of the person discharging managerial responsibilities / person closely associated | |||||
| a)
| Name | Thomas Lamb | ||||
| 2
| Reason for the notification | |||||
| a)
| Position/status
| Director | ||||
| b)
| Initial notification /Amendment | Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a)
| Name
| Mycelx Technologies Corporation | ||||
| b)
| LEI
| 213800UJZINIK2VD1G48
| ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument Identification code |
Common shares of US$0.025 USU624551235 | ||||
| b)
| Nature of the transaction | Purchase of Common Shares | ||||
| c)
| Price(s) and volume(s) |
| ||||
| d)
| Aggregated information - Aggregated volume - Price |
n/a n/a
| ||||
| e)
| Date of the transaction
| 11 March 2022 | ||||
| f)
| Place of the transaction | London Stock Exchange | ||||
| 1
| Details of the person discharging managerial responsibilities / person closely associated | |||||
| a)
| Name | Connie Mixon | ||||
| 2
| Reason for the notification | |||||
| a)
| Position/status
| Director | ||||
| b)
| Initial notification /Amendment | Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a)
| Name
| Mycelx Technologies Corporation | ||||
| b)
| LEI
| 213800UJZINIK2VD1G48
| ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument Identification code |
Common shares of US$0.025 USU624551235 | ||||
| b)
| Nature of the transaction | Purchase of Common Shares | ||||
| c)
| Price(s) and volume(s) |
| ||||
| d)
| Aggregated information - Aggregated volume - Price |
n/a n/a
| ||||
| e)
| Date of the transaction
| 11 March 2022 | ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
| 1
| Details of the person discharging managerial responsibilities / person closely associated | |||||
| a)
| Name | Andre Schnabl | ||||
| 2
| Reason for the notification | |||||
| a)
| Position/status
| Director | ||||
| b)
| Initial notification /Amendment | Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a)
| Name
| Mycelx Technologies Corporation | ||||
| b)
| LEI
| 213800UJZINIK2VD1G48
| ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument Identification code |
Common shares of US$0.025 USU624551235 | ||||
| b)
| Nature of the transaction | Purchase of Common Shares | ||||
| c)
| Price(s) and volume(s) |
| ||||
| d)
| Aggregated information - Aggregated volume - Price |
n/a n/a
| ||||
| e)
| Date of the transaction
| 11 March 2022 | ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.